These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22037208)

  • 1. A few good genes: simple, biologically motivated signatures for cancer prognosis.
    Gentles AJ; Alizadeh AA
    Cell Cycle; 2011 Nov; 10(21):3615-6. PubMed ID: 22037208
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
    Alizadeh AA; Gentles AJ; Alencar AJ; Liu CL; Kohrt HE; Houot R; Goldstein MJ; Zhao S; Natkunam Y; Advani RH; Gascoyne RD; Briones J; Tibshirani RJ; Myklebust JH; Plevritis SK; Lossos IS; Levy R
    Blood; 2011 Aug; 118(5):1350-8. PubMed ID: 21670469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
    Cerhan JR; Natkunam Y; Morton LM; Maurer MJ; Asmann Y; Habermann TM; Vasef MA; Cozen W; Lynch CF; Allmer C; Slager SL; Lossos IS; Chanock SJ; Rothman N; Hartge P; Dogan A; Wang SS
    Leuk Lymphoma; 2012 Jun; 53(6):1105-12. PubMed ID: 22066713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System.
    Omidvar N; Tekin N; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Auewarakul C; Sritana N; Cerci JJ; Dimamay MP; Gyorke T; Redondo F; Nair R; Gorospe C; Paez D; Fanti S; Ozdag H; Padua RA; Carr R
    Acta Haematol; 2020; 143(6):600-602. PubMed ID: 32187599
    [No Abstract]   [Full Text] [Related]  

  • 5. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
    Shams TM
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.
    Ding J; Dirks WG; Ehrentraut S; Geffers R; MacLeod RA; Nagel S; Pommerenke C; Romani J; Scherr M; Vaas LA; Zaborski M; Drexler HG; Quentmeier H
    Haematologica; 2015 Jun; 100(6):801-9. PubMed ID: 25769544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
    Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
    Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Analysis Between the Expression of MEF2B, and Germinal Center and Nongerminal Center Markers in Diffuse Large B-Cell Lymphoma.
    Salama A; Marcellino BK; Saad AG; Teruya-Feldstein J; Firpo-Betancourt A; Abulsayen HA; Grada Z; Hassan M; El Jamal SM
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):e63-e64. PubMed ID: 31850910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regulation of E-cadherin promoter activity by LMO2 impact on the progression and metastasis of prostate cancer].
    Peng X; Ye Z; Gao Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):385-9. PubMed ID: 24386807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.
    Atay MH; Ozatli D; Kelkitli E; Yildiz L; Turgut M; Guler N; Toptas T
    Histopathology; 2013 Aug; 63(2):293-4. PubMed ID: 23879574
    [No Abstract]   [Full Text] [Related]  

  • 11. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1 in Tumor and Tumor Microenvironment.
    Hu Z; Wang X; Cui Y; Li C; Wang S
    Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.
    Culpin RE; Sieniawski M; Angus B; Menon GK; Proctor SJ; Milne P; McCabe K; Mainou-Fowler T
    Histopathology; 2013 Dec; 63(6):788-801. PubMed ID: 24117687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
    Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
    Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
    Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells.
    Kiefer CM; Lee J; Hou C; Dale RK; Lee YT; Meier ER; Miller JL; Dean A
    Blood; 2011 Dec; 118(23):6200-8. PubMed ID: 22010104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
    Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
    Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO2 functional and transcriptional regulatory profiles in hematopoietic cells.
    Wu C; Yuan M; Gao Y; Sun W
    Leuk Res; 2018 Dec; 75():11-14. PubMed ID: 30419549
    [No Abstract]   [Full Text] [Related]  

  • 19. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
    Min M; Lin L; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.